The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Isoxazole ring as a useful scaffold in a search for new therapeutic agents
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smolen, J. S., Kalden, J. R., Scott, D. L., Rozman, B., Kvien, T. K., Larsen, A., Loew-Friedrich, I., Oed, C., & Rosenburg, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09403-3 · Cited by 771
Hsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Eccles, S. A., Massey, A., Raynaud, F. I., Sharp, S. Y., Box, G., Valenti, M., Patterson, L., de Haven Brandon, A., Gowan, S., Boxall, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5256 · Cited by 479
Mechanism of Action for Leflunomide in Rheumatoid Arthritis
Fox, R. I., Herrmann, M. L., Frangou, C. G., Wahl, G. M., Morris, R. E., Strand, V., & Kirschbaum, B. J. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4777 · Cited by 420
Targeting Hsp90: small-molecule inhibitors and their clinical development
Taldone, T., Gozman, A., Maharaj, R., & Chiosis, G. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.015 · Cited by 284
Rückemann, K., Fairbanks, L. D., Carrey, E. A., Hawrylowicz, C. M., Richards, D. F., Kirschbaum, B., & Simmonds, H. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21682 · Cited by 270
Jensen, M. R., Schoepfer, J., Radimerski, T., Massey, A., Guy, C. T., Brueggen, J., Quadt, C., Buckler, A., Cozens, R., Drysdale, M. J., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr1996 · Cited by 229
Curcumin‐Derived Pyrazoles and Isoxazoles: Swiss Army Knives or Blunt Tools for Alzheimer's Disease?
Narlawar, R., Pickhardt, M., Leuchtenberger, S., Baumann, K., Krause, S., Dyrks, T., Weggen, S., Mandelkow, E., & Schmidt, B. (2008) · ChemMedChem · doi:10.1002/cmdc.200700218 · Cited by 174
Shin, K. D., Lee, M.-Y., Shin, D.-S., Lee, S., Son, K.-H., Koh, S., Paik, Y.-K., Kwon, B.-M., & Han, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507209200 · Cited by 171
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity
Changtam, C., Hongmanee, P., & Suksamrarn, A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.003 · Cited by 163
Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety
Kang, Y. K., Shin, K. J., Yoo, K. H., Seo, K. J., Hong, C. Y., Lee, C.-S., Park, S., Kim, D. J., & Park, S. W. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00646-0 · Cited by 163
Sharp, S. Y., Prodromou, C., Boxall, K. J., Powers, M. V., Holmes, J. L., Box, G., Matthews, T. P., Cheung, K.-M. J., Kalusa, A., James, K. E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0149 · Cited by 145
Nasr, T., Bondock, S., & Eid, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.052 · Cited by 136
Vitale, P., Tacconelli, S., Perrone, M. G., Malerba, P., Simone, L., Scilimati, A., Lavecchia, A., Dovizio, M., Marcantoni, E., Bruno, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301905a · Cited by 107
Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine
Badio, B., Garraffo, H. M., Plummer, C. V., Padgett, W. L., & Daly, J. W. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00939-9 · Cited by 94
Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors
Zhao, H., Liu, G., Xin, Z., Serby, M. D., Pei, Z., Szczepankiewicz, B. G., Hajduk, P. J., Abad‐Zapatero, C., Hutchins, C. W., Lubben, T. H., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.063 · Cited by 84
Li, F., Hu, Y., Wang, Y., Ma, C., & Wang, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01852 · Cited by 75
Rajanarendar, E., Raju, S., Reddy, M. N., Krishna, S. R., Kiran, L. H., Reddy, A. R. N., & Reddy, Y. N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.004 · Cited by 66
Lilienkampf, A., Pieroni, M., Wan, B., Wang, Y., Franzblau, S. G., & Kozikowski, A. P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901273n · Cited by 65
Rajanarendar, E., Reddy, M. N., Krishna, S. R., Reddy, K. G., Reddy, Y. N., & Rajam, M. V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.013 · Cited by 63
Li, F., Ma, C., DeGrado, W. F., & Wang, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01910 · Cited by 63
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
Bass, J. Y., Caldwell, R. D., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Madauss, K. P., Marr, H. B., McFadyen, R. B., Miller, A. B., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.047 · Cited by 62
Jadhav, R. D., Kadam, K. S., Kandre, S., Guha, T., Reddy, M. M. K., Brahma, M. K., Deshmukh, N., Dixit, A. V., Doshi, L. S., Potdar, N., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.016 · Cited by 59
Bolvig, T., Larsson, O. M., Pickering, D. S., Nelson, N., Falch, E., Krogsgaard‐Larsen, P., & Schousboe, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00263-0 · Cited by 44
Design, synthesis and biological evaluation of diaziridinyl quinone isoxazole hybrids
Swapnaja, K. J. M., Yennam, S., Chavali, M. S., Poornachandra, Y., Kumar, C. G., Muthusamy, K., Jayaraman, V. B., Arumugam, P., Sridhar, B., & Sriram, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.042 · Cited by 40
New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidates
Silva, N. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01327-7 · Cited by 39
Deng, B., Zhao, Y., Hartman, T. L., Watson, K. M., Buckheit, R. W., Pannecouque, C. C., Clercq, E. D., & Cushman, M. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.09.013 · Cited by 38
Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors
Bargiotti, A., Musso, L., Dallavalle, S., Merlini, L., Gallo, G., Ciacci, A., Giannini, G., Cabri, W., Penco, S., Vesci, L., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.036 · Cited by 37
Naidu, K. M., Suresh, A., Jayanty, S., Sriram, D., Yogeeswari, P., Raghavaiah, P., & Sekhar, K. V. G. C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.043 · Cited by 37
Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase
Laufer, S., Margutti, S., & Fritz, M. D. (2005) · ChemMedChem · doi:10.1002/cmdc.200500025 · Cited by 36
Kalwat, M. A., Huang, Z., Wichaidit, C., McGlynn, K., Earnest, S. A., Savoia, C., Dioum, E. M., Schneider, J. W., Hutchison, M. R., & Cobb, M. H. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00993 · Cited by 33
Discovery of small molecular inhibitors targeting HIV-1 gp120–CD4 interaction drived from BMS-378806
Liu, T., Huang, B., Zhan, P., Clercq, E. D., & Liu, X. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.012 · Cited by 29
Synthesis and biological evaluation of GPR40/FFAR1 agonists containing 3,5-dimethylisoxazole
Yang, L., Zhang, J., Si, L., Han, L., Zhang, B., Ma, H., Xing, J., Zhao, L., Zhou, J., & Zhang, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.054 · Cited by 25
Novel coumarin isoxazoline derivatives: Synthesis and study of antibacterial activities
Suresh, G., Ratnakaram, V. N., Srinivasu, N., & Kishore, K. (2016) · Synthetic Communications · doi:10.1080/00397911.2016.1242748 · Cited by 24
Watterson, S. H., Guo, J., Spergel, S. H., Langevine, C. M., Moquin, R. V., Shen, D. R., Yarde, M., Cvijic, M. E., Banas, D., Liu, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00089 · Cited by 22
Sysak, A., Mą̨czyński, M., Ryng, S., & Obmińska‐Mrukowicz, B. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.890216 · Cited by 14
Self-citation
Cited by
The recent progress of isoxazole in medicinal chemistry
Zhu, J., Mo, J., Lin, H.-Z., Chen, Y., & Sun, H.-P. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.05.013 · Cited by 417
Dudek, B., Bąchor, U., Drozd-Szczygieł, E., Brożyna, M., Dąbrowski, P., Junka, A., & Mączyński, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216033 · Cited by 10
Metadata
- Authors
- Sysak, A., & Obmińska-Mrukowicz, B.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 137
- Pages
- 292-309
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2620932865
- Cited by
- 338
- References
- 36
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.